Classic peptide therapy has often been constrained by poor bioavailability and enzymatic stability. Despite this, cutting-edge approaches are driving a genuine shift in peptide design. New engineered peptides, https://linkedbookmarker.com/story7709855/transforming-pharmaceutical-research-with-next-generation-short-proteins